参考文献/References:
[1] Subasinghe AK,Arabshahi S,Busingye D,et al. Association between salt and hypertension in rural and urban populations of low to middle income countries:a systematic review and meta-analysis of population based studies[J]. Asia Pac J Clin Nutr,2016,25(2):402-413.
[2] Ma J,Li H. The role of gut microbiota in atherosclerosis and hypertension[J]. Front Pharmacol,2018,9:1082.
[3] Yue L,Zhang R,Chen S,et al. Relationship between helicobacter pylori and incident hypertension as well as blood pressure :a systematic review and meta-analysis[J]. Dig Dis,2023,41(1):124-137.
[4] Wan Z,Hu L,Hu M,et al. Helicobacter pylori infection and prevalence of high blood pressure among Chinese adults[J]. J Hum Hypertens ,2018,32(2):158-164.
[5] Abdel-Razik A,Mousa N,Shabana W,et al. Helicobacter pylori and non-alcoholic fatty liver disease :a new enigma?[J]. Helicobacter,2018,23(6):e12537.
[6] Temesgen GB,Menon M,Gizaw ST,et al. Evaluation of lipid profile and inflammatory marker in patients with gastric helicobacter pylori infection ,Ethiopia[J]. Int J Gen Med,2022,15:271-278.
[7] Wellen KE,Hotamisligil GS. Inflammation,stress,and diabetes[J]. J Clin Invest,2005,115(5):1111-1119.
[8] Kotsis V,Stabouli S,Papakatsika S,et al. Mechanisms of obesity-induced hypertension[J]. Hypertens Res,2010,33(5):386-393.
[9] Azami M,Baradaran HR,Dehghanbanadaki H,et al. Association of helicobacter pylori infection with the risk of metabolic syndrome and insulin resistance :an updated systematic review and meta-analysis[J]. Diabetol Metab Syndr,2021,13(1):145.
[10]Kebapcilar L,Bilgir O,Cetinkaya E,et al. The effect of helicobacter pylori eradication on macrophage migration inhibitory factor ,C-reactive protein and fetuin-a levels[J]. Clinics (Sao Paulo),2010,65(8):799-802.
[11]Fatima F,Ahsan N,Nasim A,et al. Association of fetuin-A with dyslipidemia and insulin resistance in type- Ⅱ diabetics of Pakistani population[J]. Pak J Med Sci,2020,36(2):64-68.
[12]Das S,Chattopadhyay D,Chatterjee SK,et al. Increase in PPARγ inhibitory phosphorylation by Fetuin-A through the activation of Ras-MEK-ERK pathway causes insulin resistance[J]. Biochim Biophys Acta Mol Basis Dis,2021,1867(4):166050.
[13]Akash MSH,Rehman K,Liaqat A. Tumor necrosis factor-alpha:role in development of insulin resistance and pathogenesis of type 2 diabetes mellitus[J]. J Cell Biochem,2018,119(1):105-110.
[14]Zhou X,Liu W,Gu M,et al. Helicobacter pylori infection causes hepatic insulin resistance by the c-Jun/miR-203/SOCS3 signaling pathway[J]. J Gastroenterol,2015,50(10):1027-1040.
[15]Chen Y,Xu C,Xu H,et al. Persistent helicobacter pylori infection for more than 3?years leads to elevated serum homocysteine concentration :a retrospective cohort study based on a healthy Chinese population[J]. J Gastroenterol Hepatol ,2021,36(11):3077-3083.
[16]Soyocak A,Ergun DD,Koc G,et al. Investigation of aryl hydrocarbon receptor,zinc,and vitamin B12 levels in chronic gastritis with helicobacter pylori infection[J]. Biol Trace Elem Res,2021,199(7):2431-2437.
[17]Balint B,Jepchumba VK,Guéant JL,et al. Mechanisms of homocysteine-induced damage to the endothelial,medial and adventitial layers of the arterial wall[J]. Biochimie,2020,173:100-106.
[18]Hsu WT,Ho SY,Jian TY,et al. Helicobacter pylori-derived heat shock protein 60 increases the induction of regulatory T-cells associated with persistent infection[J]. Microb Pathog,2018,119:152-161.
[19]Nemati M,Larussa T,Khorramdelazad H,et al. Toll-like receptor 2:an important immunomodulatory molecule during helicobacter pylori infection[J]. Life Sci ,2017,178:17-29.
[20] 刘庭玉,高振军,沈曼茹,等. 幽门螺杆菌感染小鼠胃内菌群、短链脂肪酸变化及丁酸盐对胃癌细胞增殖迁移的影响[J]. 山东医药,2020,60(11):34-37.
[21]Wu Y,Xu H,Tu X,et al. The role of short-chain fatty acids of gut microbiota origin in hypertension[J]. Front Microbiol,2021,12:730809.
[22]Kimura I,Inoue D,Maeda T,et al. Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41)[J]. Proc Natl Acad Sci U S A,2011,108(19):8030-8035.
[23]Wang JW,Hsu CN,Tai WC,et al. The association of helicobacter pylori eradication with the occurrences of chronic kidney diseases in patients with peptic ulcer diseases[J]. PLoS One ,2016,11(10):e0164824.
[24]Lin SY,Lin CL,Liu JH,et al. Association between helicobacter pylori infection and the subsequent risk of end-stage renal disease :a nationwide population-based cohort study[J]. Int J Clin Pract,2015,69(5):604-610.
[25]Yulizal OK,Lelo A,Ilyas S,et al. The effect of Channa striata extract and standard eradication regimen on asymmetric dimethylarginine in helicobacter pylori gastritis rat model[J]. Vet World,2020,13(8):1605-1612.
[26]Ye XW,Xiao J,Qiu T,et al. Helicobacter pylori seroprevalence in patients with obstructive sleep apnea syndrome among a Chinese population[J]. Saudi Med J,2009,30(5):693-697.
[27]Galla S,Chakraborty S,Cheng X,et al. Exposure to amoxicillin in early life is associated with changes in gut microbiota and reduction in blood pressure:findings from a study on rat dams and offspring[J]. J Am Heart Assoc,2020,9(2):e014373.
[28]Huang M,Zhu L,Jin Y,et al. Association between helicobacter pylori infection and systemic arterial hypertension :a meta-analysis[J]. Arq Bras Cardiol,2021,117(4):626-636.
[29]Xiong X,Chen J,He M,et al. Helicobacter pylori infection and the prevalence of hypertension in Chinese adults:the Dongfeng-Tongji cohort[J]. J Clin Hypertens (Greenwich),2020,22(8):1389-1395.
[30]Karadeniz Y,?zpamuk-Karadeniz F,Ahbab S,et al. Vitamin D deficiency is a potential risk for blood pressure elevation and the development of hypertension[J]. Medicina (Kaunas),2021,57(12):1297.
[31]Hu W,Zhang L,Li MX,et al. Vitamin D3 activates the autolysosomal degradation function against helicobacter pylori through the PDIA3 receptor in gastric epithelial cells[J]. Autophagy ,2019,15(4):707-725.
[32]Rahman MM,Tikhomirova A,Modak JK,et al. Antibacterial activity of ethoxzolamide against helicobacter pylori strains SS1 and 26695[J]. Gut Pathog ,2020,12:20.
[33]Pelliciari S,Pinatel E,Vannini A,et al. Insight into the essential role of the helicobacter pylori HP1043 orphan response regulator :genome-wide identification and characterization of the DNA-binding sites[J]. Sci Rep,2017,7:41063.
[34]González A,Casado J,Chueca E,et al. Repurposing dihydropyridines for treatment of helicobacter pylori infection[J]. Pharmaceutics ,2019,11(12):681.
相似文献/References:
[1]孙刚,黄冠华,综述.高血压合并心力衰竭的治疗策略[J].心血管病学进展,2016,(2):201.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.027]
SUN Gang,HUANG Guanhua.Treatment Strategy of Hypertension with Heart Failure[J].Advances in Cardiovascular Diseases,2016,(2):201.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.027]
[2]范贵娟,综述,徐瑞,等.盐敏感性高血压的研究进展[J].心血管病学进展,2016,(4):364.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.010]
FAN Guijuan,XU Rui.Research Progress of Salt Sensitive Hypertension[J].Advances in Cardiovascular Diseases,2016,(2):364.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.010]
[3]陈源源.钙通道阻滞剂在降压治疗中的应用[J].心血管病学进展,2015,(6):662.[doi:10.3969/j.issn.1004-3934.2015.06.002]
CHEN Yuanyuan.Application of Calcium Channel Blockers in Hypertension Treatment[J].Advances in Cardiovascular Diseases,2015,(2):662.[doi:10.3969/j.issn.1004-3934.2015.06.002]
[4]张瑞 毛露 孙硕 Dirk Hermann 陈艾东.内皮素-1干预成为高血压治疗新靶点的展望[J].心血管病学进展,2019,(7):969.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.000]
ZHANG Rui MAO LuSUN ShuoDIRK Hermann CHEN Aidong.The Prospect of Endothelin-1 Intervention as A New Target for the Treatment of Hypertension[J].Advances in Cardiovascular Diseases,2019,(2):969.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.000]
[5]张毅,柳志红.动态血压监测在高血压中的应用现状与问题[J].心血管病学进展,2019,(6):848.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.003]
ZHANG Yi,LIU Zhihong.Current status and nsolved Pproblems of Ambulatory Blood Pressure Monitoring for the Management of Hypertension[J].Advances in Cardiovascular Diseases,2019,(2):848.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.003]
[6]黄秋瑾 胡蓉.高血压合并糖尿病患者血压控制率和控制目标的探讨[J].心血管病学进展,2019,(7):973.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.002]
HUANG QiujinHU Rong.Discussion on Blood Pressure Control Rate and Control Target in Patients with Hypertension Complicated with Diabetes[J].Advances in Cardiovascular Diseases,2019,(2):973.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.002]
[7]张旭明 王曦.高血压对认知功能的影响[J].心血管病学进展,2019,(7):977.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.003]
ZHANG Xuming,WANG Xi.The Relationship Between Hypertension and Cognitive Function[J].Advances in Cardiovascular Diseases,2019,(2):977.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.003]
[8]凌梦军 陈明凌梦军.阻塞性睡眠呼吸暂停低通气综合征与高血压关系的研究进展[J].心血管病学进展,2019,(5):722.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.015]
[9]李波 郭毅 田进文 邓珏琳.高血压合并2型糖尿病的治疗进展[J].心血管病学进展,2019,(9):1196.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.002]
LI Bo,GUO Yi,TIAN Jinwen,et al.Therapy in Hypertensive Patients with Type 2 Diabetes Mellitus[J].Advances in Cardiovascular Diseases,2019,(2):1196.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.002]
[10]王继航 赵施皓 李开亮 田进文 李玉龙 付士辉 沈明志 邓珏琳.远程医疗在高血压病管理中的研究进展[J].心血管病学进展,2019,(9):1199.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.003]
WANG Jihang,ZHAO Shihao,LI Kailiang,et al.Telemedicine in Hypertension Management[J].Advances in Cardiovascular Diseases,2019,(2):1199.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.003]